IOSP Innospec Inc

Price (delayed)

$99.56

Market cap

$2.48B

P/E Ratio

19.04

Dividend/share

$1.34

EPS

$5.23

Enterprise value

$2.38B

Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, ...

Highlights
The stock's price to earnings (P/E) is 41% less than its 5-year quarterly average of 32.1
IOSP's gross profit is up by 26% year-on-year
Innospec's net income has increased by 22% YoY but it has decreased by 2.5% from the previous quarter
The company's EPS rose by 22% YoY but it fell by 2.6% QoQ
The debt rose by 16% year-on-year and by 8% since the previous quarter

Key stats

What are the main financial stats of IOSP
Market
Shares outstanding
24.87M
Market cap
$2.48B
Enterprise value
$2.38B
Valuations
Price to earnings (P/E)
19.04
Price to book (P/B)
2.29
Price to sales (P/S)
1.23
EV/EBIT
13.08
EV/EBITDA
10.77
EV/Sales
1.19
Earnings
Revenue
$2B
EBIT
$181.8M
EBITDA
$220.7M
Free cash flow
$76.8M
Per share
EPS
$5.23
Free cash flow per share
$3.1
Book value per share
$43.54
Revenue per share
$80.68
TBVPS
$49.07
Balance sheet
Total assets
$1.62B
Total liabilities
$543.5M
Debt
$49M
Equity
$1.08B
Working capital
$493.4M
Liquidity
Debt to equity
0.05
Current ratio
2.29
Quick ratio
1.28
Net debt/EBITDA
-0.45
Margins
EBITDA margin
11%
Gross margin
29.7%
Net margin
6.5%
Operating margin
9.2%
Efficiency
Return on assets
7.9%
Return on equity
12.1%
Return on invested capital
23.4%
Return on capital employed
14.6%
Return on sales
9.1%
Dividend
Dividend yield
1.35%
DPS
$1.34
Payout ratio
25.6%

IOSP stock price

How has the Innospec stock price performed over time
Intraday
6.21%
1 week
4.84%
1 month
-0.08%
1 year
-6%
YTD
-3.21%
QTD
-3.03%

Financial performance

How have Innospec's revenue and profit performed over time
Revenue
$2B
Gross profit
$595.2M
Operating income
$184M
Net income
$129.7M
Gross margin
29.7%
Net margin
6.5%
IOSP's gross profit is up by 26% year-on-year
The company's operating income rose by 26% YoY
Innospec's revenue has increased by 24% YoY
Innospec's net income has increased by 22% YoY but it has decreased by 2.5% from the previous quarter

Growth

What is Innospec's growth rate over time

Valuation

What is Innospec stock price valuation
P/E
19.04
P/B
2.29
P/S
1.23
EV/EBIT
13.08
EV/EBITDA
10.77
EV/Sales
1.19
The stock's price to earnings (P/E) is 41% less than its 5-year quarterly average of 32.1
The company's EPS rose by 22% YoY but it fell by 2.6% QoQ
The P/B is 4.1% more than the 5-year quarterly average of 2.2 and 4.1% more than the last 4 quarters average of 2.2
The equity is up by 3.9% from the previous quarter
Innospec's revenue has increased by 24% YoY
The price to sales (P/S) is 12% lower than the 5-year quarterly average of 1.4 and 5% lower than the last 4 quarters average of 1.3

Efficiency

How efficient is Innospec business performance
Innospec's ROE has increased by 16% YoY but it has decreased by 3.2% from the previous quarter
IOSP's ROA is up by 14% year-on-year but it is down by 2.5% since the previous quarter
IOSP's return on invested capital is up by 10% year-on-year
The company's return on sales fell by 4.2% QoQ and by 4.2% YoY

Dividends

What is IOSP's dividend history
DPS
$1.34
Dividend yield
1.35%
Payout ratio
25.6%
Recent dividends

Financial health

How did Innospec financials performed over time
Innospec's total assets is 199% more than its total liabilities
The quick ratio is up by 8% from the previous quarter
The current ratio has grown by 7% from the previous quarter and by 3.6% YoY
The debt is 95% smaller than the equity
Innospec's debt to equity has increased by 25% from the previous quarter and by 25% YoY
The debt rose by 16% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.